Company intelligence / Profile preview

ikfe CRO

Mainz, Germanypharmaceutical-business-review.com ↗

Ownership: Private
Development stage: Other

Overview

ikfe CRO was a German full-service contract research organization specializing in diabetes and cardiovascular research. It provided comprehensive support to pharmaceutical and biotechnology companies worldwide, including regulatory affairs, data management, medical writing, laboratory services, and clinical operations. The company was acquired by Clinlogix in October 2013.

Therapeutic areas: OncologyEndocrinologyCardiovascular
Modalities: Small molecule (supported in clinical trials, not as a developer)Biologic (supported in clinical trials, not as a developer)Medical device (supported in clinical trials, not as a developer)In-vitro diagnostics
Industry: Contract Research Organization

Partnerships

Associated partners included ikfe Clinic and Phase I Unit, ikfe Laboratory, and ikfe Academy prior to acquisition.

Beyond the preview

Go deeper on ikfe CRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ikfe CRO.

Explore the full profile